4889.T
Renascience Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 999.00
−0.70%Year over year
Reported trailing growth
- Revenue
- -48.5%
- EBITDA
- —
- EBIT
- -100.0%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +95.6%
- EBITDA
- —
- EPS
- -15.2%
Three-year CAGR
- Revenue
- -12.1%
- EBITDA
- —
- EBIT
- -100.0%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026